{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T04:58:55Z","timestamp":1773291535582,"version":"3.50.1"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2008,2,23]],"date-time":"2008-02-23T00:00:00Z","timestamp":1203724800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer Chemother Pharmacol"],"published-print":{"date-parts":[[2008,12]]},"DOI":"10.1007\/s00280-008-0705-y","type":"journal-article","created":{"date-parts":[[2008,2,22]],"date-time":"2008-02-22T07:00:32Z","timestamp":1203663632000},"page":"37-43","source":"Crossref","is-referenced-by-count":29,"title":["Inhibition of mitochondrial protein translation sensitizes melanoma cells to arsenic trioxide cytotoxicity via a reactive oxygen species dependent mechanism"],"prefix":"10.1007","volume":"63","author":[{"given":"Benjamin D.","family":"Bowling","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicole","family":"Doudican","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Prashiela","family":"Manga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seth J.","family":"Orlow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2008,2,23]]},"reference":[{"key":"705_CR1","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0014-5793(99)00841-8","volume":"455","author":"Y Akao","year":"1999","unstructured":"Akao Y, Nakagawa Y, Akiyama K (1999) Arsenic trioxide induces apoptosis in neuroblastoma cell lines through the activation of caspase 3 in vitro. FEBS Lett 455:59\u201362","journal-title":"FEBS Lett"},{"key":"705_CR2","unstructured":"Bael TE, PB, Thoreson M, Richmond T, Eyer J, Gollob JA (2005) Presented at the Journal of Clinical Oncology, 2005 ASCO annual meeting proceedings. Vol. 23, No. 16S, Part I of II (June 1 Supplement), 2005: 7553"},{"key":"705_CR3","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1111\/j.1365-2141.2006.06280.x","volume":"135","author":"JR Berenson","year":"2006","unstructured":"Berenson JR, Boccia R, Siegel D, Bozdech M, Bessudo A, Stadtmauer E, Talisman Pomeroy J, Steis R, Flam M, Lutzky J, Jilani S, Volk J, Wong SF, Moss R, Patel R, Ferretti D, Russell K, Louie R, Yeh HS, Swift RA (2006) Efficacy and safety of melphalan, arsenic trioxide and ascorbic acid combination therapy in patients with relapsed or refractory multiple myeloma: a prospective, multicentre, phase II, single-arm study. Br J Haematol 135:174\u2013183","journal-title":"Br J Haematol"},{"key":"705_CR4","doi-asserted-by":"crossref","first-page":"4818","DOI":"10.1128\/MCB.02360-05","volume":"26","author":"ND Bonawitz","year":"2006","unstructured":"Bonawitz ND, Rodeheffer MS, Shadel GS (2006) Defective mitochondrial gene expression results in reactive oxygen species-mediated inhibition of respiration and reduction of yeast life span. Mol Cell Biol 26:4818\u20134829","journal-title":"Mol Cell Biol"},{"key":"705_CR5","first-page":"1503","volume":"36","author":"DO Chee","year":"1976","unstructured":"Chee DO, Boddie AW, Roth JA, Holmes EC, Morton DL (1976) Production of melanoma-associated antigen(s) by a defined malignant melanoma cell strain grown in chemically defined medium. Cancer Res 36:1503\u20131509","journal-title":"Cancer Res"},{"key":"705_CR6","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1182\/blood.V88.3.1052.1052","volume":"88","author":"GQ Chen","year":"1996","unstructured":"Chen GQ, Zhu J, Shi XG, Ni JH, Zhong HJ, Si GY, Jin XL, Tang W, Li XS, Xong SM, Shen ZX, Sun GL, Ma J, Zhang P, Zhang TD, Gazin C, Naoe T, Chen SJ, Wang ZY, Chen Z (1996) In vitro studies on cellular and molecular mechanisms of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia: As2O3 induces NB4 cell apoptosis with downregulation of Bcl-2 expression and modulation of PML-RAR alpha\/PML proteins. Blood 88:1052\u20131061","journal-title":"Blood"},{"key":"705_CR7","doi-asserted-by":"crossref","first-page":"500","DOI":"10.4065\/81.4.500","volume":"81","author":"DL Cummins","year":"2006","unstructured":"Cummins DL, Cummins JM, Pantle H, Silverman MA, Leonard AL, Chanmugam A (2006) Cutaneous malignant melanoma. Mayo Clin Proc 81:500\u2013507","journal-title":"Mayo Clin Proc"},{"key":"705_CR8","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1182\/blood.V93.1.268","volume":"93","author":"J Dai","year":"1999","unstructured":"Dai J, Weinberg RS, Waxman S, Jing Y (1999) Malignant cells can be sensitized to undergo growth inhibition and apoptosis by arsenic trioxide through modulation of the glutathione redox system. Blood 93:268\u2013277","journal-title":"Blood"},{"key":"705_CR9","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1038\/sj.leu.2402876","volume":"17","author":"K Davison","year":"2003","unstructured":"Davison K, Cote S, Mader S, Miller WH (2003) Glutathione depletion overcomes resistance to arsenic trioxide in arsenic-resistant cell lines. Leukemia 17:931\u2013940","journal-title":"Leukemia"},{"key":"705_CR10","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1182\/blood-2004-05-1772","volume":"105","author":"Z Diaz","year":"2005","unstructured":"Diaz Z, Colombo M, Mann KK, Su H, Smith KN, Bohle DS, Schipper HM, Miller WH Jr (2005) Trolox selectively enhances arsenic-mediated oxidative stress and apoptosis in APL and other malignant cell lines. Blood 105:1237\u20131245","journal-title":"Blood"},{"key":"705_CR11","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1093\/jnci\/dji289","volume":"97","author":"BK Edwards","year":"2005","unstructured":"Edwards BK, Brown ML, Wingo PA, Howe HL, Ward E, Ries LA, Schrag D, Jamison PM, Jemal A, Wu XC, Friedman C, Harlan L, Warren J, Anderson RN, Pickle LW (2005) Annual report to the nation on the status of cancer, 1975\u20132002, featuring population-based trends in cancer treatment. J Natl Cancer Inst 97:1407\u20131427","journal-title":"J Natl Cancer Inst"},{"key":"705_CR12","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/S0006-291X(02)02831-0","volume":"300","author":"W Hyun Park","year":"2003","unstructured":"Hyun Park W, Hee Cho Y, Won Jung C, Oh Park J, Kim K, Hyuck Im Y, Lee MH, Ki Kang W, Park K (2003) Arsenic trioxide inhibits the growth of A498 renal cell carcinoma cells via cell cycle arrest or apoptosis. Biochem Biophys Res Commun 300:230\u2013235","journal-title":"Biochem Biophys Res Commun"},{"key":"705_CR13","unstructured":"Islam M, Kirkwood JM (2001) Arsenic trioxide induces apoptosis of human melanoma cell lines in vitro. Proc Am Soc Clin Oncol: 2001 (abstr 1435)"},{"key":"705_CR14","first-page":"562","volume":"3","author":"WP Jambor","year":"1955","unstructured":"Jambor WP, Steinberg BA, Suydam LO (1955) Thiostrepton, a new antibiotic. III. In vivo studies. Antibiot Annu 3:562\u2013565","journal-title":"Antibiot Annu"},{"key":"705_CR15","doi-asserted-by":"crossref","first-page":"2102","DOI":"10.1182\/blood.V94.6.2102","volume":"94","author":"Y Jing","year":"1999","unstructured":"Jing Y, Dai J, Chalmers-Redman RM, Tatton WG, Waxman S (1999) Arsenic trioxide selectively induces acute promyelocytic leukemia cell apoptosis via a hydrogen peroxide-dependent pathway. Blood 94:2102\u20132111","journal-title":"Blood"},{"key":"705_CR16","first-page":"3976","volume":"53","author":"SH Kaufmann","year":"1993","unstructured":"Kaufmann SH, Desnoyers S, Ottaviano Y, Davidson NE, Poirier GG (1993) Specific proteolytic cleavage of poly (ADP-ribose) polymerase: an early marker of chemotherapy-induced apoptosis. Cancer Res 53:3976\u20133985","journal-title":"Cancer Res"},{"key":"705_CR17","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1002\/cncr.21386","volume":"104","author":"KB Kim","year":"2005","unstructured":"Kim KB, Bedikian AY, Camacho LH, Papadopoulos NE, McCullough C (2005) A phase II trial of arsenic trioxide in patients with metastatic melanoma. Cancer 104:1687\u20131692","journal-title":"Cancer"},{"key":"705_CR18","doi-asserted-by":"crossref","first-page":"2042","DOI":"10.1128\/AAC.01411-05","volume":"50","author":"EE McKee","year":"2006","unstructured":"McKee EE, Ferguson M, Bentley AT, Marks TA (2006) Inhibition of mammalian mitochondrial protein synthesis by oxazolidinones. Antimicrob Agents Chemother 50:2042\u20132049","journal-title":"Antimicrob Agents Chemother"},{"key":"705_CR19","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.molcel.2007.01.014","volume":"25","author":"D Pan","year":"2007","unstructured":"Pan D, Kirillov SV, Cooperman BS (2007) Kinetically competent intermediates in the translocation step of protein synthesis. Mol Cell 25:519\u2013529","journal-title":"Mol Cell"},{"key":"705_CR20","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/j.leukres.2003.11.018","volume":"28","author":"A Raza","year":"2004","unstructured":"Raza A, Buonamici S, Lisak L, Tahir S, Li D, Imran M, Chaudary NI, Pervaiz H, Gallegos JA, Alvi MI, Mumtaz M, Gezer S, Venugopal P, Reddy P, Galili N, Candoni A, Singer J, Nucifora G (2004) Arsenic trioxide and thalidomide combination produces multi-lineage hematological responses in myelodysplastic syndromes patients, particularly in those with high pre-therapy EVI1 expression. Leuk Res 28:791\u2013803","journal-title":"Leuk Res"},{"key":"705_CR21","doi-asserted-by":"crossref","first-page":"10173","DOI":"10.1073\/pnas.180290497","volume":"97","author":"EM Rego","year":"2000","unstructured":"Rego EM, He LZ, Warrell RP Jr, Wang ZG, Pandolfi PP (2000) Retinoic acid (RA) and As2O3 treatment in transgenic models of acute promyelocytic leukemia (APL) unravel the distinct nature of the leukemogenic process induced by the PML-RARalpha and PLZF-RARalpha oncoproteins. Proc Natl Acad Sci USA 97:10173\u201310178","journal-title":"Proc Natl Acad Sci USA"},{"key":"705_CR22","doi-asserted-by":"crossref","first-page":"9586","DOI":"10.1073\/pnas.96.17.9586","volume":"96","author":"MV Rodnina","year":"1999","unstructured":"Rodnina MV, Savelsbergh A, Matassova NB, Katunin VI, Semenkov YP, Wintermeyer W (1999) Thiostrepton inhibits the turnover but not the GTPase of elongation factor G on the ribosome. Proc Natl Acad Sci USA 96:9586\u20139590","journal-title":"Proc Natl Acad Sci USA"},{"key":"705_CR23","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1006\/bbrc.1999.1697","volume":"265","author":"JG Seol","year":"1999","unstructured":"Seol JG, Park WH, Kim ES, Jung CW, Hyun JM, Kim BK, Lee YY (1999) Effect of arsenic trioxide on cell cycle arrest in head and neck cancer cell line PCI-1. Biochem Biophys Res Commun 265:400\u2013404","journal-title":"Biochem Biophys Res Commun"},{"key":"705_CR24","first-page":"21","volume":"19","author":"L Serrone","year":"2000","unstructured":"Serrone L, Zeuli M, Sega FM, Cognetti F (2000) Dacarbazine-based chemotherapy for metastatic melanoma: thirty-year experience overview. J Exp Clin Cancer Res 19:21\u201334","journal-title":"J Exp Clin Cancer Res"},{"key":"705_CR25","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1056\/NEJM199811053391901","volume":"339","author":"SL Soignet","year":"1998","unstructured":"Soignet SL, Maslak P, Wang ZG, Jhanwar S, Calleja E, Dardashti LJ, Corso D, DeBlasio A, Gabrilove J, Scheinberg DA, Pandolfi PP, Warrell RP Jr (1998) Complete remission after treatment of acute promyelocytic leukemia with arsenic trioxide. N Engl J Med 339:1341\u20131348","journal-title":"N Engl J Med"},{"key":"705_CR26","doi-asserted-by":"crossref","unstructured":"Tarhini AA, Kirkwood JM, Gooding WE, Stuckert JJ, Agarwala SS (2007) Presented at the American Society of Clinical Oncology (abstr 8569)","DOI":"10.1200\/jco.2007.25.18_suppl.8569"},{"key":"705_CR27","first-page":"4957","volume":"6","author":"R Uslu","year":"2000","unstructured":"Uslu R, Sanli UA, Sezgin C, Karabulut B, Terzioglu E, Omay SB, Goker E (2000) Arsenic trioxide-mediated cytotoxicity and apoptosis in prostate and ovarian carcinoma cell lines. Clin Cancer Res 6:4957\u20134964","journal-title":"Clin Cancer Res"},{"key":"705_CR28","first-page":"3283","volume":"46","author":"C Bogert van den","year":"1986","unstructured":"van den Bogert C, Dontje BH, Holtrop M, Melis TE, Romijn JC, van Dongen JW, Kroon AM (1986) Arrest of the proliferation of renal and prostate carcinomas of human origin by inhibition of mitochondrial protein synthesis. Cancer Res 46:3283\u20133289","journal-title":"Cancer Res"},{"key":"705_CR29","first-page":"1489","volume":"24","author":"XX Wu","year":"2004","unstructured":"Wu XX, Ogawa O, Kakehi Y (2004) Enhancement of arsenic trioxide-induced apoptosis in renal cell carcinoma cells by L-buthionine sulfoximine. Int J Oncol 24:1489\u20131497","journal-title":"Int J Oncol"},{"key":"705_CR30","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1016\/S0959-8049(99)00106-9","volume":"35","author":"TC Zhang","year":"1999","unstructured":"Zhang TC, Cao EH, Li JF, Ma W, Qin JF (1999) Induction of apoptosis and inhibition of human gastric cancer MGC-803 cell growth by arsenic trioxide. Eur J Cancer 35:1258\u20131263","journal-title":"Eur J Cancer"},{"key":"705_CR31","doi-asserted-by":"crossref","first-page":"6423","DOI":"10.1016\/j.febslet.2005.09.103","volume":"579","author":"L Zhang","year":"2005","unstructured":"Zhang L, Ging NC, Komoda T, Hanada T, Suzuki T, Watanabe K (2005) Antibiotic susceptibility of mammalian mitochondrial translation. FEBS Lett 579:6423\u20136427","journal-title":"FEBS Lett"}],"container-title":["Cancer Chemotherapy and Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00280-008-0705-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00280-008-0705-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00280-008-0705-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,2]],"date-time":"2020-05-02T05:39:50Z","timestamp":1588397990000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00280-008-0705-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,2,23]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008,12]]}},"alternative-id":["705"],"URL":"https:\/\/doi.org\/10.1007\/s00280-008-0705-y","relation":{},"ISSN":["0344-5704","1432-0843"],"issn-type":[{"value":"0344-5704","type":"print"},{"value":"1432-0843","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,2,23]]}}}